(Q41335040)

29 September 2017

1 reference

title

The treatment of acute leukaemia (English)

1 reference

29 September 2017

1 reference

A K Burnett

1

1 reference

29 September 2017

O B Eden

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

29 September 2017

1 reference

29 September 2017

volume

349

1 reference

29 September 2017

issue

9047

1 reference

29 September 2017

page(s)

270-275

1 reference

Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Stem cell origins of leukaemia and curability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908086-5

7 January 2021

10.1016/S0140-6736(96)08086-5

Identifiers

DOI

1 reference

29 September 2017

1 reference